Candel Therapeutics, Inc. (CADL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 299.22M |
| Enterprise Value | 181.39M |
| P/E Ratio | -9.31 |
| PEG Ratio | 0.11 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 7.72 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -9.74 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.43 |
| Return On Equity | -0.89 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -35.22M |
| Net Income | -38.18M |
| Diluted EPS | -0.72 |
| Total Cash | 201.57M |
| Total Cash/Share | 2.72 |
| Total Debt | 49.52M |
| Total Debt/Equity | 0.39 |
| Current Ratio | 16.09 |
| Book Value Per Share | 1.7 |
| 52-Week Change | 120.67 |
| 52-Week High | 13.82 |
| 52-Week Low | 4.35 |
| Moving Average 50 Days | 10.07 |
| Moving Average 200 Days | 6.98 |
| Average Volume | 1.65M |
| Shares Outstanding | 73.27M |
| % Held by Institutions | 69.64 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |